Europe Cancer Screening Market (2018-2023)

  • Product Code:
    RP-ID-10009675
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    75
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-13

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Europe cancer screening market

Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.

By end users, the market is segmented into hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.
By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.
By application type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.
By countries, the market is divided into the United Kingdom (U.K.), France and Germany.

Key growth factors

Rise in the aging population, changing environmental conditions along with the adoption of a sedentary lifestyle is contributing to more cancer-related cases.

Threats and key players

Stringent regulations along with regulatory inter and intra state barriers pose many challenges for the region. Lack of associated funding and transparency in medical procedures turn out to be as threats to the market.
Key players in the European cancer screening market are F. Hoffman-La- Roche Ltd, Bayer AG, and Johnson & Johnson, Pfizer, Merck & co.

What is covered in the report?

1. Overview of the European cancer screening market.
2. Market drivers and challenges in the European cancer screening market.
3. Market trends in the European cancer screening market.
4. Historical, current and forecasted market size data for Europe market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics) - by type of screening (laboratory, genetic, imaging, biopsy and endoscopy) -by application (lung, breast, melanoma, kidney and colorectal).
5. Historical, current and forecasted market size data for Europe market segmentation based on end-users (hospitals, laboratories, independent physicians and clinics) - by type of screening type(laboratory, genetic, imaging, biopsy and endoscopy) -by application (lung, breast, melanoma, kidney and colorectal).
6. Historical, current and forecasted market size data of the cancer screening market by countries UK, Germany and Others (Other parts of Europe) - by revenue .
7. Historical, current and forecasted market size data for country-wise segments - by revenue.
8. Analysis of the competitive landscape and profiles of major competitors operating in the European market.

Why buy?

o Understand the demand for the cancer screening market to determine the viability of the market.
o Understand the country-specific market size and observations for each segment.
o Develop strategies based on the drivers, trends and highlights for each of the segments.
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
o Recognize the key competitors of this market and respond accordingly.
o Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
o Define the competitive positioning by comparing the products and services compared with the key players in the market.

Customizations available

With the given market data, Kenneth Research offers customizations according to specific needs. Write to us at sales@kennethresearch.com.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
1. F. Hoffman La Roche Ltd
2. Bayer AG
3. Johnson & Johnson
4. Pfizer
5. Merck & Co.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->